The incidence of adverse events following the use of the drug is classified according to WHO recommendations: very frequent -> 10%; frequent -> 1% and <10%; infrequent -> 0.1% and <1%; rare -> 0.01% and <0.1%; very rare - <0.01%; unknown frequency - based on available data, the frequency can not be estimated.
Immune system disorders: rare - allergic reactions (skin itching, urticaria), very rare - anaphylactic shock, Quincke's edema, atopic dermatitis.
General disorders and disorders at the site of administration: rare - irritation, burning sensation and numbness of the nasal mucosa.
Other: rare - dry mouth, red eyes.
In case of detection of undesirable reactions, including those not indicated in these instructions for use, discontinue use of the drug and consult a doctor.